The One21 Technique: An Individualized Treatment for Glabellar Lines Based on Clinical and Anatomical Landmarks

References

• Carruthers JD, Carruthers JA. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol. 1992;18:17–21. doi:10.1111/j.1524-4725.1992.tb03295.x
   PubMed Web of Science ®Google Scholar
• Dorizas A, Krueger N, Sadick NS. Aesthetic uses of the botulinum toxin. Dermatol Clin. 2014;32:23–36. doi:10.1016/j.det.2013.09.009
   PubMed Web of Science ®Google Scholar
• Martinez AM. Visual perception of facial expressions of emotion. Curr Opin Psychol. 2017;17:27–33. doi:10.1016/j.copsyc.2017.06.009
   Web of Science ®Google Scholar
• Cox SE, Finn JC. Social implications of hyperdynamic facial lines and patient satisfaction outcomes. Int Ophthalmol Clin. 2005;45:13–24. doi:10.1097/01.iio.0000167237.49396.7b
   PubMedGoogle Scholar
• Miot HA, Penna GO, Ramos AMC, et al. Profile of dermatological consultations in Brazil (2018). An Bras Dermatol. 2018;93:916–928. doi:10.1590/abd1806-4841.20188802
   PubMed Web of Science ®Google Scholar
• Carruthers A, Carruthers J. Botulinum toxin type A: history and current cosmetic use in the upper face. Semin Cutan Med Surg. 2001;20:71–84. doi:10.1053/sder.2001.25138
   PubMed Web of Science ®Google Scholar
• Carruthers JD, Lowe NJ, Menter MA, Gibson J, Eadie N. Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines. Plast Reconstr Surg. 2003;112:1089–1098. doi:10.1097/01.PRS.0000076504.79727.62
   PubMed Web of Science ®Google Scholar
• Carruthers JA, Lowe NJ, Menter MA, et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol. 2002;46:840–849. doi:10.1067/mjd.2002.121356
   PubMed Web of Science ®Google Scholar
• de Almeida AR, da Costa Marques ER, Banegas R, Kadunc BV. Glabellar contraction patterns: a tool to optimize botulinum toxin treatment. Dermatol Surg. 2012;38:1506–1515. doi:10.1111/j.1524-4725.2012.02505.x
   PubMed Web of Science ®Google Scholar
• Sattler G, Callander MJ, Grablowitz D, et al. Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines. Dermatol Surg. 2010;36(Suppl 4):2146–2154. doi:10.1111/j.1524-4725.2010.01706.x
   Web of Science ®Google Scholar
• Flynn TC, Carruthers A, Carruthers J, et al. Validated assessment scales for the upper face. Dermatol Surg. 2012;38:309–319. doi:10.1111/j.1524-4725.2011.02248.x
   PubMed Web of Science ®Google Scholar
• Rappl T, Parvizi D, Friedl H, et al. Onset and duration of effect of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in the treatment of glabellar frown lines: a randomized, double-blind study. Clin Cosmet Investig Dermatol. 2013;6:211–219. doi:10.2147/CCID.S41537
   Google Scholar
• Ingallina F, Poulain B, Trevidic P. Anatomy & Botulinum toxin injections.
   Google Scholar
• Zarins U.
   Google Scholar
• Cook BE Jr, Lucarelli MJ, Lemke BN. Depressor supercilii muscle: anatomy, histology, and cosmetic implications. Ophthalmic Plast Reconstr Surg. 2001;17:404–411. doi:10.1097/00002341-200111000-00004
   Web of Science ®Google Scholar
• Sykes JM, Trevidic P, Suarez GA, Criollo-Lamilla G. Newer understanding of specific anatomic targets in the aging face as applied to injectables: facial muscles–identifying optimal targets for neuromodulators. Plast Reconstr Surg. 2015;136:56S–61S. doi:10.1097/PRS.0000000000001731
   Web of Science ®Google Scholar
• Trevidic P, Cauchois R, Ingallina F. [Facial anatomy and botulinum toxin: the muscular balances]. Ann Dermatol Venereol. 2009;136(Suppl 4):S61–6. French. doi:10.1016/S0151-9638(09)74529-6
   Web of Science ®Google Scholar
• Abramo AC, Do Amaral TP, Lessio BP, De Lima GA. Anatomy of forehead, glabellar, nasal and orbital muscles, and their correlation with distinctive patterns of skin lines on the upper third of the face: reviewing concepts. Aesthetic Plast Surg. 2016;40:962–971. doi:10.1007/s00266-016-0712-z
   Web of Science ®Google Scholar
• Sundaram H, Signorini M, Liew S, et al. Global aesthetics consensus: botulinum toxin type a–evidence-based review, emerging concepts, and consensus recommendations for aesthetic use, including updates on complications. Plast Reconstr Surg. 2016;137:518e–29e. doi:10.1097/01.prs.0000475758.63709.23
   PubMed Web of Science ®Google Scholar
• Carruthers J, Fournier N, Kerscher M, Ruiz-Avila J, Trindade de Almeida AR, Kaeuper G. The convergence of medicine and neurotoxins: a focus on botulinum toxin type A and its application in aesthetic medicine–a global, evidence-based botulinum toxin consensus education initiative: part II: incorporating botulinum toxin into aesthetic clinical practice. Dermatol Surg. 2013;39:510–525. doi:10.1111/dsu.12148
   Web of Science ®Google Scholar
• Yutskovskaya Y, Gubanova E, Khrustaleva I, et al. IncobotulinumtoxinA in aesthetics: russian multidisciplinary expert consensus recommendations. Clin Cosmet Investig Dermatol. 2015;8:297–306. doi:10.2147/CCID.S72301
   PubMedGoogle Scholar
• de Maio M, Swift A, Signorini M, Fagien S. Facial assessment and injection guide for botulinum toxin and injectable hyaluronic acid fillers: focus on the upper face. Plast Reconstr Surg. 2017;140:265e–76e. doi:10.1097/PRS.0000000000003544
   PubMed Web of Science ®Google Scholar
• Miot HA. Assessing normality of data in clinical and experimental trials. J Vasc Bras. 2017;16:88–91. doi:10.1590/1677-5449.041117
   PubMedGoogle Scholar
• Miot HA. Análise de dados ordinais em estudos clínicos e experimentais. J Vascular Brasileiro. 2013;39:e20200185. doi:10.1590/1677-5449.200185
   Google Scholar
• Miot HA. Sample size in clinical and experimental studies. J Vasc Bras. 2011;10:275–278. doi:10.1590/S1677-54492011000400001
   Google Scholar
• Abramo AC. Muscle insertion and strength of the muscle contraction as guidelines to enhance duration of the botulinum toxin effect in the upper face. Aesthetic Plast Surg. 2018;42:1379–1387. doi:10.1007/s00266-018-1157-3
   Web of Science ®Google Scholar
• Carruthers A, Carruthers J, Said S. Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females. Dermatol Surg. 2005;31:414–22; discussion 22. doi:10.1097/00042728-200504000-00007
   Web of Science ®Google Scholar
• Carruthers A, Carruthers J, Coleman WP 3rd, et al. Multicenter, randomized, Phase III study of a single dose of incobotulinumtoxinA, free from complexing proteins, in the treatment of glabellar frown lines. Dermatol Surg. 2013;39:551–558. doi:10.1111/dsu.12100
   Web of Science ®Google Scholar